Walgreens Boots Alliance (NASDAQ:WBA) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Walgreens Boots Alliance (NASDAQ:WBA - Free Report) in a research report released on Tuesday. The brokerage issued a hold rating on the pharmacy operator's stock.

A number of other equities research analysts have also recently commented on WBA. Wolfe Research upgraded Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Truist Financial cut their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, January 31st. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their price objective for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Evercore ISI upped their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a report on Monday, January 13th. Finally, Royal Bank of Canada lifted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a research note on Wednesday, January 15th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $10.59.

Remove Ads

Walgreens Boots Alliance Trading Down 0.0 %

WBA stock traded down $0.01 during mid-day trading on Tuesday, reaching $11.12. The company's stock had a trading volume of 11,537,604 shares, compared to its average volume of 20,630,177. The business's 50 day moving average price is $10.97 and its 200 day moving average price is $9.81. Walgreens Boots Alliance has a 12 month low of $8.08 and a 12 month high of $22.05. The company has a market cap of $9.61 billion, a price-to-earnings ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company's quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.66 earnings per share. On average, equities research analysts predict that Walgreens Boots Alliance will post 1.6 EPS for the current year.

Institutional Investors Weigh In On Walgreens Boots Alliance

Hedge funds have recently added to or reduced their stakes in the company. DSG Capital Advisors LLC bought a new position in Walgreens Boots Alliance during the fourth quarter valued at approximately $164,000. Wealth Enhancement Advisory Services LLC boosted its position in Walgreens Boots Alliance by 117.4% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 186,834 shares of the pharmacy operator's stock valued at $1,743,000 after buying an additional 100,888 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at about $2,821,000. Yoffe Investment Management LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at about $102,000. Finally, LifeWealth Investments LLC purchased a new position in shares of Walgreens Boots Alliance in the fourth quarter worth about $97,000. Institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.